Elosulfase alfa structure
|
Common Name | Elosulfase alfa | ||
|---|---|---|---|---|
| CAS Number | 9025-60-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Elosulfase alfaElosulfase alfa (BMN 110) is a recombinant form of human N-acetylgalactosamine-6-sulfatase (GALNS). Elosulfase alfa is used as an enzyme replacement therapy for mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A syndrome[1]. |
| Name | Elosulfase alfa |
|---|
| Description | Elosulfase alfa (BMN 110) is a recombinant form of human N-acetylgalactosamine-6-sulfatase (GALNS). Elosulfase alfa is used as an enzyme replacement therapy for mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A syndrome[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Sanford M, et al. Elosulfase alfa: first global approval. Drugs. 2014 Apr;74(6):713-8. |
| No Any Chemical & Physical Properties |